Evolent Health (EVH)
(Delayed Data from NYSE)
$22.19 USD
+0.92 (4.33%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $22.18 -0.01 (-0.05%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Evolent Health (EVH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$41.36 | $63.00 | $28.00 | 86.39% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Evolent Health comes to $41.36. The forecasts range from a low of $28.00 to a high of $63.00. The average price target represents an increase of 86.39% from the last closing price of $22.19.
Analyst Price Targets (14)
Broker Rating
Evolent Health currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.20 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, 13 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 86.67% and 6.67% of all recommendations. A month ago, Strong Buy made up 86.67%, while Buy represented 6.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 13 | 13 | 13 | 13 | 13 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/1/2024 | Truist Securities | Jailendra Singh | Hold | Hold |
5/30/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
5/10/2024 | JMP Securities | Constantine Kyriakos Davides | Strong Buy | Strong Buy |
5/9/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
4/22/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/1/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
3/28/2024 | Canaccord Genuity | Richard Close | Strong Buy | Strong Buy |
3/1/2024 | Stephens | Jeffrey Garro | Strong Buy | Strong Buy |
3/1/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
2/23/2024 | Piper Sandler | Jessica E Tassan | Strong Buy | Strong Buy |
2/7/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
1/7/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
1/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
10/16/2023 | UBS | Kevin Caliendo | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.20 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 15 |
Average Target Price | $41.36 |
LT Growth Rate | NA |
Industry | Internet - Software |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | 0.21 |